인간배아줄기세포의 연구 규제와 불특허사유

• 영문명: Regulation on Embryonic Stem Cells and Non-patentability
• 발행기관: 한국사법학회(구 한국비교사법학회)
• 저자명: 김병일(Byungil Kim)
• 간행물 정보: 『비교사법』比較私法 제15권 제4호, 649~681쪽, 전체 33쪽
• 주제분류: 법학 > 법학
• 파일형태: PDF
• 발행일자: 2008.12.30

영문 초록

This thesis investigates the patentability of human embryonic stem cells in Europe, the US and Koran. Patenting of human embryonic stem cells contrary to morality? Biotechnology patents have always been controversial to moral standards. The issue raised by the 1998 EU Directive is whether patents on human embryonic stem cells should be granted or not, and the question is still in discussion. The facts are that such patents have already been granted in the US. This paper review the moral problems, which arise in Europe in relation to stem cell patents and the implementation of the Directive according to EC law and according to the EPS system. Furthermore, this paper makes some comments on the EPO decision of November 27, 2008 and raised specific ethical questions related to fundamental ethical principles about the patenting of inventions involving human stem cells. Finally I will try to analyse the complexity of problems and finding the balance regarding the future development in the legislation of stem cells patentability.

목차

Ⅰ. 서언

Ⅱ. 인간배아줄기세포

Ⅲ. 인간배아줄기세포 연구에 관한 규제

Ⅳ. 인간배아줄기세포에 관한 발명의 특허성 : 인간배아의 파괴는 공서약속 위반?

Ⅴ. 결어

【참고문헌】

[Abstract]

키워드

생명윤리 특허 불특허사유 인간배아줄기세포 공서(公序) Bioethics Patent Non-patentability Human Embryonic Stem Cell Order Public